Literature DB >> 27178014

Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature.

Darshan Singh1, Suresh Narayanan2, Balasingam Vicknasingam3.   

Abstract

INTRODUCTION: The objective of the paper was to highlight the differences in the traditional and non-traditional users of kratom in the South East Asian and Western contexts.
METHOD: A literature survey of published kratom studies among humans was conducted. Forty published studies relevant to the objective were reviewed.
RESULTS: Apart from the differences in the sources of supply, patterns of use and social acceptability of kratom within these two regions, the most interesting finding is its evolution to a recreational drug in both settings and the severity of the adverse effects of kratom use reported in the West. While several cases of toxicity and death have emerged in the West, such reports have been non-existent in South East Asia where kratom has had a longer history of use. We highlight the possible reasons for this as discussed in the literature. More importantly, it should be borne in mind that the individual clinical case-reports emerging from the West that link kratom use to adverse reactions or fatalities frequently pertained to kratom used together with other substances. Therefore, there is a danger of these reports being used to strengthen the case for legal sanction against kratom. This would be unfortunate since the experiences from South East Asia suggest considerable potential for therapeutic use among people who use drugs.
CONCLUSION: Despite its addictive properties, reported side-effects and its tendency to be used a recreational drug, more scientific clinical human studies are necessary to determine its potential therapeutic value.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug; Fatality; Ketum; Kratom; Mitragynine; Recreational; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 27178014     DOI: 10.1016/j.brainresbull.2016.05.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  24 in total

1.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

2.  Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.

Authors:  Albert Garcia-Romeu; David J Cox; Kirsten E Smith; Kelly E Dunn; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2020-02-03       Impact factor: 4.492

3.  The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.

Authors:  Rob Hill; Andrew C Kruegel; Jonathan A Javitch; J Robert Lane; Meritxell Canals
Journal:  Br J Pharmacol       Date:  2022-03-30       Impact factor: 9.473

4.  Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.

Authors:  Norsyifa Harun; Illa Syafiqah Johari; Sharif Mahsufi Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2019-12-12       Impact factor: 4.530

5.  Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.

Authors:  Rhiannon Bath; Tanner Bucholz; Amy F Buros; Darshan Singh; Kirsten E Smith; Charles A Veltri; Oliver Grundmann
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

Review 6.  Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.

Authors:  Dimy Fluyau; Neelambika Revadigar
Journal:  Front Psychiatry       Date:  2017-04-24       Impact factor: 4.157

Review 7.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

8.  Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Kok Leng Tan; Salbiah Mohd Isa; Nur Sabrina Yusoff; Nelson Jeng Yeou Chear; Darshan Singh
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

9.  Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study.

Authors:  Balasingam Vicknasingam; Weng Tink Chooi; Azlan Abdul Rahim; Dinesh Ramachandram; Darshan Singh; Surash Ramanathan; Nur Sabrina Mohd Yusof; Hadzliana Zainal; Vikneswaran Murugaiyah; Ralitza Gueorguieva; Sharif Mahsufi Mansor; Marek C Chawarski
Journal:  Yale J Biol Med       Date:  2020-06-29

10.  Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Destiny Schriefer; Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.